Key Takeaways HOLX saw Breast Health revenues fall 2.1% and 6.9% in Q1 and Q2, citing weak capital equipment demand.Hologic restructured sales teams to sharpen focus between capital and disposable product channels.HOLX's direct sales of Endomagnetics products aim to expand reach and stabilize revenue streams.Hologic (HOLX) has built a resilient Breast Health business, with its mammography products holding a leading market share. The division struggled this year, with revenues decreasing 2.1% and 6.9% in the ...